A commonly used pesticide, rotenone, is a mitochondrial respiratory complex I inhibitor capable of selective oxidation of mitochondrial phospholipid, cardiolipin (CL). Given that rotenone exposure is associated with the development of Parkinson disease (PD), we hypothesized that CL peroxidized molecular species accompanying mitochondrial dysfunction may represent a new biomarker of PD. In this study, we used circulating lymphocytes isolated from human blood and found that rotenone (50-250microM, 12-18h) caused apoptosis (phosphatidylserine externalization, caspase 3/7 activation), reactive oxygen species production (superoxide, H2O2), mitochondrial dysfunction (inactivation of complex I, decrease of mitochondria membrane potential, depletion of ATP) and activation of peroxidase activity of mitochondria. Using an oxidative lipidomics approach, we found that treatment of lymphocytes with rotenone resulted in accumulation of monolyso-CL and oxygenated free fatty acids. In addition we were able to detect oxygenated molecular species of tetra-linoleyl CL, a major CL molecular species in lymphocytes. Notably, molecular species of oxygenated CL formed in human lymphocytes were similar to those formed in cyt c driven reaction in the presence of H2O2 - in line with the known participation of cytochrome as a catalyst of CL peroxidation during apoptosis. Using the combination of lipidomics and oxidative epitope-targeted enzymatic digestion of oxidized tetralinoleoyl-CL we found that its oxygenated LA species were represented by hydroxy- and hydroperoxy-derivatives. Thus, we conclude that CL and its oxygenation products and metabolites may represent a new biomarker of rotenone-induced mitochondrial dysfunction associated with PD.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.